Press releases

From January 2013: New site speaker at DZNE Witten

Federal Minister Schavan inaugurates new DZNE and University of Ulm institutes

Bonn, December 20^th, 2012. Scientists at the German Center for Neurodegenerative Diseases (DZNE) in Bonn have gained new insights into the early phase of the brain’s development. In cooperation with researchers of the Max Planck Institute of Neurobiology, the University of…

Bonn, December 19^th, 2012. Researchers in Bonn, Germany, have identified a protein as a potential target for the treatment of Alzheimer’s disease. The molecular complex is part of the immune system and a driving force for inflammatory responses of the brain. Blocking its…

Collaboration between two Helmholtz Centres: Neuroscientists and infection researchers focus on interdisciplinary partnership to study brain diseases

DZNE researchers are studying movement disorders within the framework of the EU's NEUROMICS project

Göttingen, November 30^th, 2012. Researchers at the German Center for Neurodegenerative Diseases (DZNE) and the University Medical Center Göttingen (UMG) have identified an enzyme as a possible target for the treatment of Alzheimer’s disease. The protein known as HDAC6…

Joint Press Release of the German Center for Neurodegenerative Diseases and the Max Planck Research Unit for Enzymology of Protein Folding

Bonn/München/Frankfurt, November 23^rd2012. Prof. Thomas Misgeld from the German Center for Neurodegenerative Diseases (DZNE) as well as the Technischen Universität München and Prof. Boris Schmidt, Technische Universität Darmstadt, have been awarded with the 2012 Hans and…

Magdeburg, 8^th of November 2012. The feel-good hormone dopamine improves long-term memory. This is the finding of a team lead by Emrah Düzel, neuroscientist at the German Center for Neurodegenerative Diseases (DZNE) and the University of Magdeburg. The researchers…